Correlation Between Shinhan Inverse and AptaBio Therapeutics
Can any of the company-specific risk be diversified away by investing in both Shinhan Inverse and AptaBio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shinhan Inverse and AptaBio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shinhan Inverse Silver and AptaBio Therapeutics, you can compare the effects of market volatilities on Shinhan Inverse and AptaBio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shinhan Inverse with a short position of AptaBio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shinhan Inverse and AptaBio Therapeutics.
Diversification Opportunities for Shinhan Inverse and AptaBio Therapeutics
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Shinhan and AptaBio is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Shinhan Inverse Silver and AptaBio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AptaBio Therapeutics and Shinhan Inverse is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shinhan Inverse Silver are associated (or correlated) with AptaBio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AptaBio Therapeutics has no effect on the direction of Shinhan Inverse i.e., Shinhan Inverse and AptaBio Therapeutics go up and down completely randomly.
Pair Corralation between Shinhan Inverse and AptaBio Therapeutics
Assuming the 90 days trading horizon Shinhan Inverse Silver is expected to generate 0.42 times more return on investment than AptaBio Therapeutics. However, Shinhan Inverse Silver is 2.41 times less risky than AptaBio Therapeutics. It trades about -0.01 of its potential returns per unit of risk. AptaBio Therapeutics is currently generating about -0.01 per unit of risk. If you would invest 413,500 in Shinhan Inverse Silver on August 26, 2024 and sell it today you would lose (61,500) from holding Shinhan Inverse Silver or give up 14.87% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 98.16% |
Values | Daily Returns |
Shinhan Inverse Silver vs. AptaBio Therapeutics
Performance |
Timeline |
Shinhan Inverse Silver |
AptaBio Therapeutics |
Shinhan Inverse and AptaBio Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Shinhan Inverse and AptaBio Therapeutics
The main advantage of trading using opposite Shinhan Inverse and AptaBio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shinhan Inverse position performs unexpectedly, AptaBio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AptaBio Therapeutics will offset losses from the drop in AptaBio Therapeutics' long position.Shinhan Inverse vs. AptaBio Therapeutics | Shinhan Inverse vs. Daewoo SBI SPAC | Shinhan Inverse vs. Dream Security co | Shinhan Inverse vs. Microfriend |
AptaBio Therapeutics vs. ABL Bio | AptaBio Therapeutics vs. Helixmith Co | AptaBio Therapeutics vs. OliX PharmaceuticalsInc | AptaBio Therapeutics vs. Oscotec |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Bonds Directory Find actively traded corporate debentures issued by US companies |